The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis
Abstract
The growth of human breast tumor cells is regulated through signaling involving cell surface growth factor receptors and nuclear receptors of the steroid/thyroid/retinoid receptor gene family. Retinoic acid receptors (RARs), members of the steroid/thyroid hormone receptor gene family, are ligand-dependent transcription factors, which have in vitro and in vivo growth inhibitory activity against breast cancer cells. RAR-agonists inhibit the proliferation of many human breast cancer cell lines, particularly those whose growth is stimulated by estradiol (E2) or growth factors. Additionally, RAR-agonists and synthetic retinoids such as Ferentinide have been shown to induce apoptosis in malignant breast cells but not normal breast cells. To better define the genes involved in RAR-mediated growth inhibition of breast cancer cells, we used oligonucleotide microarray analysis to create a database of genes that are potentially regulated by RAR-agonists in breast cancer cells. We found that PDCD4 (programmed cell death 4), a tumor suppressor gene presently being evaluated as a target for chemoprevention, was induced about three-fold by the RARalpha-selective agonist Am580, in T-47D breast cancer cells. RAR pan-agonists and Am580, but not retinoid X receptors (RXR)-agonists, stimulate the expression of PDCD4 in a wide variety of retinoid-inhibited breast cancer cell lines. RAR-agonists did not induce PDCD4 expression in breast cancer cell lines, which were not growth inhibited by retinoi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“its loss is diagnostic for human cancer staging and prognostic for survival in colon, lung, liver, breast, glioma and esophageal cancers (6–11).”
From Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65 (2014) · cites this paper as [6]
In the citing paper
“PDCD4 is a pro-apoptotic tumor suppressor gene and has been verified as a miR-21 target in human colorectal and breast cancer cell lines (Afonja et al., 2004; Asangani et al., 2007; Bitomsky et al., 2008; Frankel et al., 2007; Lu et al., 2008; Zhang et al., 2006).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Afonja et al., 2004
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.Preprint
Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., & Evans, R. M. (1992) · Genes & Development · doi:10.1101/gad.6.3.329 · Cited by 1,193
Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids.
Allenby, G., Bocquel, M. T., Saunders, M., Kazmer, S., Speck, J., Rosenberger, M., Lovey, A. J., Kastner, P., Grippo, J. F., & Chambon, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.1.30 · Cited by 755
Yang, H.-S., Jansen, A. P., Komar, A. A., Zheng, X., Merrick, W. C., Costes, S., Lockett, S. J., Sonenberg, N., & Colburn, N. H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.26-37.2003 · Cited by 494
Retinoids and their receptors in cancer development and chemoprevention
Sun, S., & Lotan, R. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00144-5 · Cited by 324
A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
Fanjul, A. N., Dawson, M. I., Hobbs, P. D., Jong, L., Cameron, J. F., Harlev, E., Graupner, G., Lu, X. P., & Pfahl, M. (1994) · Nature · doi:10.1038/372107a0 · Cited by 313
Molecular targets for breast cancer therapy and prevention
Bange, J., Zwick, E., & Ullrich, A. (2001) · Nature Medicine · doi:10.1038/87872 · Cited by 291
Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis
Chen, Y., Knösel, T., Kristiansen, G., Pietas, A., Garber, M. E., Matsuhashi, S., Ozaki, I., & Petersen, I. (2003) · The Journal of Pathology · doi:10.1002/path.1378 · Cited by 265
Self-citationJurisicova, A., Latham, K. E., Casper, R. F., & Varmuza, S. (1998) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199811)51:3 · Cited by 264
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254
Self-citationRetinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity
Kagechika, H., Kawachi, E., Hashimoto, Y., Shudo, K., & Himi, T. (1988) · Journal of Medicinal Chemistry · doi:10.1021/jm00119a021 · Cited by 235
Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death
Shibahara, K., Asano, M., Ishida, Y., Aoki, T., Koike, T., & Honjo, T. (1995) · Gene · doi:10.1016/0378-1119(95)00607-9 · Cited by 223
Yang, H.-S., Jansen, A. P., Nair, R., Shibahara, K., Verma, A. K., Cmarik, J. L., & Colburn, N. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204137 · Cited by 185
Salbert, G., Fanjul, A. N., Piedrafita, F. J., Lu, X., Kim, S. J., Tran, P., & Pfahl, M. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264664 · Cited by 160
Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation
Yang, H.-S., Knies, J. L., Stark, C., & Colburn, N. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206433 · Cited by 160
Le, X., Claret, F.-X., Lammayot, A., Tian, L., Deshpande, D. M., LaPushin, R., Tari, A. M., & Bast, R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300848200 · Cited by 151
Schaer, J., Waser, B., Mengod, G., & Reubi, J. C. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970304)70:5 · Cited by 151
Mangelsdorf, D. J. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1994.tb01385.x · Cited by 136
Jansen, A. P., Camalier, C. E., Stark, C., & Colburn, N. H. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.103.3.2 · Cited by 132
Sheikh, M. S., Shao, Z., Li, X. S., Dawson, M. I., Jetten, A. M., Wu, S., Conley, B. A., Garcia, M., Rochefort, H., & Fontana, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31823-9 · Cited by 106
Azzoni, L., Zatsepina, O., Abebe, B., Bennett, I. M., Kanakaraj, P., & Perussia, B. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3493 · Cited by 105
The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA
Böhm, M., Sawicka, K., Siebrasse, J. P., Brehmer-Fastnacht, A., Peters, R., & Klempnauer, K.-H. (2003) · Oncogene · doi:10.1038/sj.onc.1206710 · Cited by 101
Mangiarotti, R., Danova, M., Alberici, R., & Pellicciari, C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.32 · Cited by 92
Zhang, Z., & DuBois, R. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204588 · Cited by 90
Afonja, O., Raaka, B. M., Huang, A. J., Das, S., Zhao, X., Helmer, E., Juste, D., & Samuels, H. H. (2002) · Oncogene · doi:10.1038/sj.onc.1205985 · Cited by 86
Self-citationRetinoid-sensitive cells and cell lines
Amos, B., & Lotan, R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)90026-w · Cited by 77
Her2/neu induces all-transretinoic acid (ATRA) resistance in breast cancer cells
Tari, A. M., Lim, S.-J., Hung, M., Esteva, F. J., & Lopez‐Berestein, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205660 · Cited by 71
Lombet, A., Zujovic, V., Kandouz, M., Billardon, C., Carvajal‐Gonzalez, S., Gompel, A., & Rostène, W. H. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02002.x · Cited by 62
Yoshinaga, H., Matsuhashi, S., Fujiyama, C., & Masaki, Z. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00995.x · Cited by 62
Self-citationGianni’, M., Calzi, M. L., Terao, M., Guiso, G., Caccia, S., Barbui, T., Rambaldi, A., & Garattini, E. (1996) · Blood · doi:10.1182/blood.v87.4.1520.bloodjournal8741520 · Cited by 61
Harada, M., Matsunaga, K., Oguchi, Y., Iijima, H., Tamada, K., Abe, K., Takenoyama, M., Ito, O., Kimura, G., & Nomoto, K. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970127)70:3 · Cited by 56
Cloning of the TIS gene suppressed by topoisomerase inhibitors
Onishi, Y., Hashimoto, S., & Kizaki, H. (1998) · Gene · doi:10.1016/s0378-1119(98)00313-8 · Cited by 47
Seewaldt, V. L., Caldwell, L. E., Johnson, B. S., Swisshelm, K. L., Collins, S. J., & Tsai, S. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3694 · Cited by 46
Pratt, M. A. C., Niu, M.-Y., & White, D. M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10682 · Cited by 43
Soejima, H., Miyoshi, O., Yoshinaga, H., Masaki, Z., Ozaki, I., Kajiwara, S., Niikawa, N., Matsuhashi, S., & Mukai, T. (1999) · Cytogenetic and Genome Research · doi:10.1159/000015408 · Cited by 43
Self-citationNiu, M.-Y., Ménard, M., Reed, J. C., Krajewski, S., & Pratt, M. A. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204453 · Cited by 42
Orlandi, M., Mantovani, B., Ammar, K., Avitabile, E., Monte, P. D., & Bartolini, G. (2003) · Medical Principles and Practice · doi:10.1159/000070753 · Cited by 35
Retinoid Receptors in Human Breast Carcinoma: Possible Modulators of in Situ Estrogen Metabolism
Suzuki, T., Moriya, T., Sugawara, A., Ariga, N., Takabayashi, H., & Sasano, H. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006433929792 · Cited by 28
Han, Q., Allegretto, E. A., Shao, Z., Kute, T. E., Ordóñez, J. V., Aisner, S. C., Rishi, A. K., & Fontana, J. A. (1997) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199702000-00007 · Cited by 28
Dietze, E. C., Caldwell, L. E., Marcom, K., Collins, S. J., Yee, L., Swisshelm, K. L., Hobbs, K. B., Bean, G. R., & Seewaldt, V. L. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10174 · Cited by 26
Ye, X.-F., Wu, Q., Liu, S., Lin, X.-F., Zhang, B., Wu, J.-F., Cai, J.-H., Zhang, M.-Q., & Su, W.-J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00143-2 · Cited by 23
Offterdinger, M., Schneider, S. M., & Grunt, T. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10237 · Cited by 17
An antigen expressed in proliferating cells at late G1-S phase
Matsuhashi, S., Watanabe, T., & Hori, K. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90312-0 · Cited by 12
Self-citationTyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells
Grunt, T. W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00512-8 · Cited by 10
Research works printed but not linked: 2
- Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–159. · DOI
- Jansen AP, Dean M and Colburn NH . (2003). Proc. Amer. Assoc. Cancer Res., 44, 938 (Abstract #4723).
Cited by
Sorted by citations
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer
Frescas, D., & Pagano, M. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2396 · Cited by 903
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626
“PDCD4 is a proapoptotic tumor suppressor gene and has been verified as a miR-21 target in human colorectal and breast cancer cell lines (Afonja et al., 2004; Asangani et al., 2008; Bitomsky et al., 2008; Frankel et al., 2008; Lu et al., 2008; Zhang et al., 2006).”
Wang, L., Cho, K. B., Li, Y., Tao, G., Xie, Z., & Guo, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225758 · Cited by 604
Peart, M. J., Smyth, G. K., van Laar, R. K., Bowtell, D. D. L., Richon, V. M., Marks, P. A., Holloway, A. J., & Johnstone, R. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500369102 · Cited by 538
Transcriptional profiling of the LPS induced NF-κB response in macrophages
Sharif, O., Bolshakov, V. N., Raines, S., Newham, P., & Perkins, N. D. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-1 · Cited by 513
Metadata
- Authors
- Afonja, O., Juste, D., Das, S., Matsuhashi, S., & Samuels, H. H.
- Affiliations
- New York University (US)
- Saga University (JP)
- Corresponding author
- Afonja, Olubunmi
- ORCID
- Das, Sharmistha
- Venue
- Oncogene
- Published
- 2004-09-13
- Volume
- 23
- Issue
- 49
- Pages
- 8135-8145
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2071878775
- Cited by
- 154
- References
- 47
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 8 · 2021: 1 · 2020: 5 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 5 · 2015: 13 · 2014: 13 · 2013: 10 · 2012: 9
- FWCI
- 2.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Robert Wood Johnson Foundation
- National Cancer Institute (K12 CA 01713, K12CA001713)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK16636)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- PDCD4, retinoic acid receptor agonists, breast cancer, apoptosis, tumor suppressor gene expression, antiestrogens, trastuzumab, AM580, retinoids, gene expression profiling, T47D cells, MDA-MB-231 cells, chemoprevention, retinoid X receptor
- MeSH terms
- Breast Neoplasms, Cell Cycle, Estrogen Antagonists, Humans, Transcription Factors, Gene Expression Regulation, Neoplastic, RNA-Binding Proteins, Apoptosis, Receptors, Retinoic Acid, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Cell Line, Tumor, Retinoid X Receptors, Apoptosis Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
